Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangzhou Zi Xiu Tang Biotechnology is a Chinese health and wellness company that specialized in the production and distribution of weight loss supplements and beauty products. The company is most widely recognized for its Zi Xiu Tang Bee Pollen capsules, which were marketed globally as a natural solution for weight management. However, the company faced significant regulatory scrutiny when health authorities, including the U.S. FDA, discovered that its products contained undeclared and banned pharmaceutical substances like sibutramine and phenolphthalein. These findings led to widespread product recalls, import bans, and the eventual cessation of its primary international operations. Despite being marketed as herbal supplements, the presence of synthetic drugs posed serious cardiovascular risks to consumers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangzhou Zi Xiu Tang Biotechnology.